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Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory disorder that primarily affects the synovial joints.
Rheumatoid vasculitis (RV) is an extra-articular manifestation of RA, and its association with aortitis is rare and not
widely recognised. Here, we report the case of a 69-year-old woman with RA-associated aortitis and review the
literature on rheumatoid aortitis. The mean oral steroid dose administered to RA-associated aortitis patients was
46.3 mg/day prednisolone (PSL). In our patient, the aortitis was also thought to be due to RV because she had
findings of RV, such as cutaneous ulceration and a high rheumatoid factor titre, and because a moderate PSL dose
dramatically improved the clinical findings. RA-associated aortitis, if left untreated, can be fatal; therefore, early
detection and treatment initiation is very important.
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Aortitis is a vasculitis that affects large arteries more
often than other vasculitides. According to the Chapel
Hill Consensus Conference (CHCC) 2012 definitions,
Takayasu arteritis (TKA) and giant cell arteritis (GCA)
are the two major variants (Jennette et al. 2013). Other
autoimmune diseases associated with aortitis are anky-
losing spondylitis (AS), Behçet’s disease, rheumatoid
arthritis (RA), and systemic lupus erythematosus (SLE).
In addition, aortitis is associated with infectious diseases,
such as syphilis and tuberculosis.
Rheumatoid arthritis is an autoimmune and systemic
inflammatory disorder mainly affecting the synovial joints.
Sometimes, RA patients have extra-articular manifesta-
tions, such as rheumatoid vasculitis (RV). The concept of
RV started to evolve in the 1960s when vasculitis with
significant clinical manifestations was described in RA
patients (Schmid et al. 1961; Bywaters and Scott 1963;
Wikinson and Torrance 1967). The clinical manifestations
of vasculitis are varied and include weakness, weight loss,
skin rashes, cutaneous ulcerations, gangrene, peripheral
neuropathy, and visceral infarction; approximately 90% of
RA patients with RV have skin manifestations (Jennette* Correspondence: my.shunta22@gmail.com; hiroyuki_yjp2005@yahoo.co.jp
Division of Rheumatic Diseases, National Center for Global Health and
Medicine, 1-21-1 Toyama, Shinjuku, Tokyo 162-8655, Japan
© 2014 Kaneko et al.; licensee Springer. This is
Attribution License (http://creativecommons.or
in any medium, provided the original work is pet al. 2013). The association of aortitis with RV is rare
and is not widely recognised. RA aortitis was originally
described by Mallory in 1936 (Mallory 1936) and has
been noted in earlier reports (Schmid et al. 1961; Bywaters
and Scott 1963; Wikinson and Torrance 1967). In 45 cases
of active non-infectious aortitis seen among 513 consecu-
tive ascending aortic resections, approximately 4% were
RA patients, as reported by Miller et al. (2006).
Here, we describe a case of aortitis associated with RA
and review the literature.Patient and methods
We report a case of aortitis associated with RA and
reviewed 24 cases among 13 publications on RA aortitis.
To identify published cases of RA aortitis, we performed
a PubMed search using the following terms: “rheumatoid
arthritis”, “autoimmune disorder”, “aortitis”, “Takayasu
aortitis”, and “large vessel vasculitis”.
We evaluated epidemiological data such as the age at
onset of RA and aortitis, interval between the onset of RA
and that of aortitis, pathology and laboratory findings,
and human leukocyte antigen (HLA) type. The ethics
committee of our institute approved this study.an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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In April 2010, a 69-year-old woman presented to our
hospital with pain and swelling in the small joints of her
hands for the past 2 months. The laboratory examination
revealed an elevated erythrocyte sedimentation rate (ESR;
31 mm/h) and C-reactive protein (CRP; 1.69 mg/L) level.
Her rheumatoid factor (RF) and anticyclic citrullinated
peptide (anti-CCP) levels were 215.4 and 51.1 IU/mL,
respectively. Subsequent radiography showed interstitial
pneumonia (nonspecific interstitial pneumonia [NSIP]
pattern), which was suggestive of RA. From these findings,
the patient was diagnosed with RA according to the
2010 American College of Rheumatology (ACR)/European
League Against Rheumatism (EULAR) RA Classification
Criteria (8 points total: joint involvement 3 points, ser-
ology 3 points, acute-phase reactants 1 point, duration
of symptoms 1 point). RA treatment was initiated with
1,000 mg/day salazosulfapyridine (SASP), which improved
her clinical symptoms and laboratory findings. Based on
the clinical course, however, SASP was not sufficiently
effective after 1 year of treatment; consequently, the
treatment was supplemented with 3 mg/day tacrolimus.
Subsequently, her articular symptoms and laboratory
inflammatory findings resolved.
In January 2014, she visited our outpatient clinic with
a fever of 38–39°C, cough, and upper back pain for the
past 1 week. She also had a skin ulcer over the right
patella that had appeared 1 month earlier (Figure 1A-1).
The laboratory evaluation revealed elevated inflammatory
markers (ESR 119 mm/h and CRP 14.99 mg/dL). Her
rheumatoid factor (RF) and matrix metalloproteinase-3
(MMP-3) levels were 2,010.0 IU/mL and 122.4 IU/L,
respectively. The C3 and C4 levels were reduced to 122.0
and 12.7 mg/dL, respectively. Cytoplasmic pattern anti-
neutrophil cytoplasmic antibodies (C-ANCA), perinuclear
ANCA (P-ANCA), antinuclear antibodies, anti-DNA,
anti-Sm, RNP, Scl-70, and Ro and La antibodies were
all negative. Three sets of blood cultures were negative.
The rapid plasma reagin (RPR) test, Treponema palli-
dum haemagglutination assay (TPHA), QuantiFERON
test (QFT), galactomannan antigen, and β-D-glucan were
negative. An echocardiogram showed no evidence of
vegetations in her heart. Thoracic-abdominal computed
tomography (CT) was performed to investigate the per-
sistently elevated inflammatory markers and showed no
evidence of pneumonia, while dilation of the ascending
and descending aorta, aortic arch, brachiocephalic artery,
and left subclavian artery were noted (Figure 2). In
addition, there was no evidence of atherosclerosis or
aneurysm or the risk factors for bacterial aneurysm.
Subsequently, fluorodeoxyglucose-positron emission tom-
ography/CT (FDG-PET/CT) showed strong abnormal
tracer uptake consistent with the dilated aortas on CT
(Figure 3A). Moreover, FDG uptake was observed in theskin ulcer on the knee (Figure 1B). Although skin from
the ulcer was biopsied, no obvious vasculitis findings were
observed (Figure 1C).
First, anti-bacterial therapy was initiated; however, this
did not resolve the fever or the elevated ESR and CRP
and did not decrease the dilation of the aorta on radiog-
raphy. Therefore, we suspected autoimmune aortitis and
initiated steroid therapy (prednisolone [PSL], 30 mg/day)
7 days after initiating the antibiotic therapy. One day
after steroid therapy was started, the patient’s fever abated,
her upper back pain disappeared, and the inflammation
markers began to decrease. The right knee skin ulcer also
shrank markedly (Figure 1A-2). These abnormalities
returned to normal within 1 month after initiating steroid
therapy. On day 28 following steroid therapy initiation,
follow-up CT showed that the dilation of the aorta had
disappeared completely (Figure 4). In addition, on day
42 after steroid initiation, FDG-PET revealed that the
abnormal intense tracer uptake by the aorta had also
disappeared (Figure 3B1-2). After the prednisolone dose
was reduced to 27.5 mg/day, the patient was discharged.
Literature review and assessment of our case
We have reported a case of aortitis associated with RA
and reviewed 24 cases from 13 studies of RA aortitis
(Table 1) (Sandring and Weil 1961; Falicov and Cooney
1964; Reimer et al. 1976; Rush et al. 1986; Sketchler and
Waxman 1987; Mimura1 and Sueishi 1989; Gravallese
et al. 1989; Towned et al. 1991; Nakabayashi et al. 1998;
Korkmaz et al. 2001; Miller et al. 2006; Verweij1 et al.
2012; Mariani and Alexander 2013). As shown in Table 1,
the mean patient ages at the times of diagnosis of RA
and aortitis were 49 ± 14.5 (range 16–74) and 56 ± 15.2
(range 16–82) years, respectively. The average time
elapsed between the onset of RA and the development
of aortitis was 6.4 ± 8.68 (range −11 to 26) years. Extra-
aortic arteritis involvement was found in 11/21 cases
(52.4%). Regarding the pathology findings of RA aortitis,
granulomas were found in 6/14 cases (42.9%), giant cells
in 3/14 cases, and atherosclerosis in 14/18 cases (77.8%).
Regarding the laboratory findings, RF was positive in 20/
23 cases (87.0%), and rheumatoid nodules were noted in
11/21 cases (52.4%). The mean oral steroid dose for aorti-
tis in the seven patients for whom the dose was reported
was 46.3 (range 0–100) mg/day PSL. In addition, two
patients were given intravenous steroids, one patient was
given a single course of steroid pulse therapy with methyl-
PSL 250 mg followed by a post-treatment 40 mg PSL dose,
and one patient was given intravenous PSL 100 mg and
intravenous cyclophosphamide (IVCY). The RA treat-
ments prior to onset of aortitis varied.
In our patient, the onsets of RA and aortitis occurred at
ages 69 and 73 years, respectively, making this patient older
than those reported previously. Other reports observed
Figure 1 Cutaneous ulceration before and after steroid therapy; pathology and PET/CT findings of the cutaneous ulceration. (A-1)
The right knee cutaneous ulcer measured 4 cm before steroid therapy. (A-2) One month after the treatment, it measured < 1 cm and showed
granulation tissue growth. (B) A biopsy of the edge of the ulcer revealed a mild lymphocytic infiltrate in the superficial dermis; however, no
obvious findings of vasculitis were observed. (C) FDG PET/CT demonstrated increased tracer uptake in the ulcer, suggesting inflammation.
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patients, with findings suggestive of severe RA. Consistent
with these observations, our patient had a concurrent skin
ulcer. As treatment, PSL was administered at 30 mg/day, a
dose comparable to the mean reported steroid dose.
Discussion
Although we have found case reports on RA-related
aortic lesions, this is not yet a widely recognised compli-
cation and is considered rare (Towned et al. 1991). By
contrast, AS-related aortitis is widely known, and the
early literature indicates there was a time when it was
difficult to differentiate between aortitis resulting from
RA versus AS (Bulkley and Roberts 1973; Clark et al.
1957). It is relatively easy to differentiate aortitis in RA
from that in AS based on the clinical course, laboratory
results, and radiological tests, even though the two have
similar pathological findings (Towned et al. 1991).
Lymphoplasmacytic infiltration, necrosis of the medial
smooth muscle cells, and elastic fibre loss are findings
common to both AS and RA aortitis. In comparison, a
rheumatoid granuloma is a characteristic feature thatcan be clearly differentiated and is seen only in aortitis
associated with RA. In addition, TKA and GCA account
for many autoimmune aortitis cases. It is reportedly diffi-
cult to differentiate the pathological findings of the aorta
in these two diseases based on the 2012 CHCC. There are
reports of concurrent RA and TKA (Jennette et al. 2013),
but like the aortitis from AS, it is difficult to determine
whether the aortitis is associated with RA or TKA based
on pathology.
RV has been reported to result primarily from vascu-
litis of small and medium-sized vessels (Genta* et al.
2006). However, many reports have stated that RV occurs
in the aorta, a very large vessel (Sandring and Weil 1961;
Falicov and Cooney 1964; Reimer et al. 1976; Rush et al.
1986; Sketchler and Waxman 1987; Mimura1 and Sueishi
1989; Gravallese et al. 1989; Towned et al. 1991;
Nakabayashi et al. 1998; Korkmaz et al. 2001; Miller
et al. 2006; Verweij1 et al. 2012; Mariani and Alexander
2013). RA-associated aortitis essentially occurs in patients
with severe RA, indicating an association with RV
(Towned et al. 1991). The following risk factors for RV
onset have been reported: high-titre rheumatoid factors,
Figure 3 FDG-PET/CT findings of aortitis before and after steroid therapy. A-1 and A-2. FDG PET/CT showed increased tracer uptake in the
ascending aorta, aortic arch, brachiocephalic artery, and left subclavian artery. B-1 and B-2. After steroid therapy, FDG-PET/CT showed a significant
reduction in the FDG uptake in the same area.
Figure 2 Thoracic contrast enhanced CT findings of aortitis before steroid therapy. Thoracic contrast-enhanced CT demonstrated thickening
of the aortic wall at each following level with a contrast effect, and the non-contrast layered area on the lumen. A. brachiocephalic artery and left
subclavian artery. B. aortic arch. C and D. ascending aorta.
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Figure 4 Thoracic contrast-enhanced CT findings of aortitis before and after steroid therapy. A-1 and A-2. Before steroid therapy, the
thoracic contrast-enhanced CT demonstrated thickening of the aortic wall at the level of the ascending aorta and aortic arch, brachiocephalic artery,
and left subclavian artery with a contrast effect. B-1 and B-2. After steroid therapy, the thickening of the aortic wall had disappeared completely.
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erosions, and presence of rheumatoid nodules (Voskuyl
et al. 1996). The first two features were observed in our
patient. Furthermore, our patient exhibited a skin ulcer,
which has been reported in approximately 90% of RV
patients (Genta* et al. 2006). However, the patient’s skin
biopsy showed no findings suggestive of vasculitis. This
might be because the biopsy specimen was obtained
from a relatively shallow site; vasculitis might have been
detected if the deeper dermal layer had been sampled.
It is also entirely possible that the skin ulcer was caused
by vasculitis based on the following observations: “no
findings suggesting history of trauma, pressure ulcer, or
infection”; “vasculitis is the first cause suspected when
a deep skin ulcer is observed”, as in this patient; “FDG-
PET/CT shows FDG uptakes at the ulcer site, suggesting
inflammation”; and “the patient responded well to steroid
treatment”. Confirmation that our patient’s skin ulcer
resulted from vasculitis would satisfy the Scott and Bacon
criteria (Turesson and Jacobsson 2004) for RV, and it is
entirely possible that the aortitis in our patient was
associated with RV.
A genetic analysis recognised HLA-DRB1*0401 as a
risk factor for RV, and approximately 5% and 21% of RV
patients are HLA-DRB1*0401 homozygotes and hetero-
zygotes, respectively (Perdriger et al. 1997). HLA-B51 and
B52, but not HLA-DRB1*0401, were detected in our case.HLA-B51 (Mizushima 1988) and HLA-B52 (Kimura et al.
2000) are associated with Behçet’s disease and TKA,
respectively. These diseases are associated with aortitis.
Behçet’s disease was not suspected in our patient, as she
did not present the associated findings of oral aphthous
ulcers, eye lesions such as uveitis, and genital ulcers. It is
unlikely that the aortitis in our case was TKA, as aortitis
onset occurred at 74 years of age, while TKA predomin-
antly affects individuals <50 years of age. Furthermore, our
patient both met the 2010 ACR/EULAR criteria and experi-
enced interstitial pneumonia, which are suggestive of RA.
Oral PSL at a 30-mg/day dose dramatically improved the
clinical findings of aortitis in our patient. Our literature
review suggests that the mean PSL dose for aortitis is 46.3
(range 10–100) mg; therefore, a moderate dose of PSL
could cure aortitis. Nevertheless, Ellen et al. reported that
ten RA-associated aortitis patients died of congestive heart
failure, aortic rupture, and acute myocardial infarction;
furthermore, most of these patients were not diagnosed
with aortitis until after death; therefore, they did not receive
any steroid or immunosuppressant therapy. These cases
suggest that RA-associated aortitis is a severe disease that
can be fatal if left untreated.
Conclusion
We reported a patient who presented with RV findings,
such as cutaneous ulceration and a high-titre rheumatoid













treatmentGranuloma Giant cells Atherosclerosis
1 6 68/F ND ND – + – ND ND ND NSAIDs NSAIDs
2 6 71/F ND ND – + + ND ND ND NSAIDs NSAIDs
3 7 63/F 23 – ND ND + ND + ND ND Steroid
4 7 65/F 10 ND ND ND + + + ND ND Steroid
5 8 16/F 0 + ND ND ND – – ND Steroid NSAIDs
6 9 49/F 5 + + + – + + ND NSAIDs, Gold, PSL Digitalis
7 10 37/F −11* – ND ND ND + + DR4 NSAIDs, CQ, Gold PSL 40 mg
8 11 53/F 0 + ND ND ND – – ND NSAIDs, HCQ PSL 60 mg
9 12 50/F 0 – – – – – + ND NSAIDs –
10 13 46/M 9 + – – + + + ND Aspirin –
11 13 52/F 26 + – – + + + ND Steroid, Aspirin –
12 13 60/M 12 + – – + + + ND Steroid, HCQ, Gold, CYC –
13 13 61/F 11 – + – + + + ND Steroid, Gold, Aspirin High-dose steroid
14 13 61/F 3 – + – + + + ND Steroid, HCQ, Gold –
15 13 64/F 3 – + – + + + ND Steroid, HCQ, Gold –
16 13 67/M 2 + – – + + + ND Steroid –
17 13 68/M 21 + + – + + + ND Steroid, HCQ –
18 13 69/M 1 + + – + + + ND Steroid, Gold, SASP –
19 13 82/F 8 + – – – – – ND Steroid, HCQ Low-dose steroid
20 14 44/M ND + ND ND ND + + ND Steroid, SASP PSL 100 mg, IVCY 5 mg/kg
21 15 64/F 4 – ND ND + + + DR2,12(5) ND PSL 10 mg
22 16 36/F 2 – ND ND ND ND + DR4,1 SASP, MTX PSL 50 mg
23 17 49/F 1 – ND ND ND – + ND Steroid, MTX, LEF PSL 40 mg, bosentan
24 18 43/F ND – ND ND ND – + ND MTX, ADA mPSL 250 mg, PSL 40 mg
25 Present case 73/F 4 + ND ND + – + B51, B52 SASP, TAC PSL 30 mg
Abbreviations: M male, F female, + positive, − negative, RA rheumatoid arthritis, RF rheumatoid factor, HLA human leukocyte antigen, ND not described, NSAIDs non-steroidal anti-inflammatory drugs, PSL
prednisolone, mPSL methylprednisolone, CYC cyclophosphamide, CQ chloroquine, HCQ hydroxychloroquine, SASP salazosulfapyridine, LEF leflunomide, MTX methotrexate, ADA adalimumab, TAC tacrolimus, IVCY intravenous
cyclophosphamide, ND not described.
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dose of PSL dramatically improved her clinical findings.
The early detection and treatment of RA aortitis is im-
portant because RA aortitis can be fatal if left untreated.
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